UCAM and IMIB patent a new use for two drugs to prevent and treat covid-19
Researchers from the two institutions have carried out in-vitro development with Zeaxanthin and Kukoamine A to prevent the virus from entering the cell
Researchers led by Izpisua develop an accurate, quick and portable test to diagnose COVID-19 and track mutant strains
It can analyze 96 samples at the same time, identifying Sars-CoV-2 with its variants, influenza viruses, adenoviruses and other human coronaviruses. In only 15 minutes it starts giving results and in three hours it finishes all the samples.